Prostate Cancer
Reports from Netherlands and United States describe recent advances in prostate cancer research
Published in Cancer Weekly, September 12th, 2006
Study 1: Prostate cancer patients experienced improved freedom from failure (FFF) after radiotherapy dose was raised from 68 to 78 Gy.
Researchers in the Netherlands conducted a study "to determine whether a dose of 78 Gy improves outcome compared with a conventional dose of 68 Gy for prostate cancer patients treated with three-dimensional conformal radiotherapy. Between June 1997 and February 2003, stage T1b-4 prostate cancer patients were enrolled onto a multicenter randomized trial comparing 68 Gy with 78 Gy. Patients were stratified by institution, age,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-09-12)
More Articles from Cancer Weekly
- Breast Cancer
Breast cancer outcome associated with status of p53 and MDM2 SNP309 - Crohn Colitis
Crohn colitis patients requiring surgery linked to higher risk of dysplasia and adenocarcinoma - End-of-Life Issues
End-of-life cancer patients' spiritual needs measured by Spiritual Needs Inventory - Endometrial Cancer
Endometrioid endometrial carcinoma's loss of PTEN expression linked to cyclin D1 overexpression - Lung Cancer
Lung cancer patients could safely receive higher doses of radiation than traditionally administered - Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia remission is likely when lymphangiogenesis factor is absent - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
